Cargando…

Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients

BACKGROUND: Immunotherapy has become the fastest‐adopting treatment paradigm for lung cancer with improved survival. By binding with its ligand (inducible T‐cell co‐stimulator and its ligand [ICOSL]), an inducible T‐cell co‐stimulator (ICOS) could contribute to reversing immunosuppression and improv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Xiao‐Kai, Liu, Xi‐Kun, Zhang, Sen, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614122/ https://www.ncbi.nlm.nih.gov/pubmed/37850501 http://dx.doi.org/10.1002/ame2.12355

Ejemplares similares

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Mutational status of main driver genes influences the prognosis of stage I–III lung adenocarcinoma patients underwent radical surgery
por: Liao, Hongliang, et al.
Publicado: (2021)

Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma
por: Fu, Tao, et al.
Publicado: (2016)

The chicken type III GnRH receptor homologue is predominantly expressed in the pituitary, and exhibits similar ligand selectivity to the type I receptor
por: Joseph, Nerine T, et al.
Publicado: (2009)

Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma
por: Sun, Fenghao, et al.
Publicado: (2020)

Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma
por: Deng, Yujie, et al.
Publicado: (2022)

Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
por: Hohaus, S, et al.
Publicado: (1999)

An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma
por: Xu, Yuan, et al.
Publicado: (2022)

Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2022)

Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces
por: Ye, Ronghao, et al.
Publicado: (2023)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020)

Squalene synthase predicts poor prognosis in stage I‐III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression
por: Jiang, Huihong, et al.
Publicado: (2022)

Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma
por: Tian, Yiping, et al.
Publicado: (2022)

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
por: Xie, Hui, et al.
Publicado: (2021)

Clinicopathological characteristics and outcomes in stage I–III mucinous gastric adenocarcinoma: a retrospective study at a single medical center
por: Hsu, Jun-Te, et al.
Publicado: (2016)

MTA1 is an indicator of prognosis in Chinese patients with lung adenocarcinoma
por: Deng, Yue, et al.
Publicado: (2020)

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer
por: Nakamura, Naoki, et al.
Publicado: (2018)

The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
por: Li, Xiangde, et al.
Publicado: (2019)

A systematic review and meta-analysis of the influence of STAS on the long-term prognosis of stage I lung adenocarcinoma
por: Yang, Yanhui, et al.
Publicado: (2021)

A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma
por: Lu, Yiyu, et al.
Publicado: (2016)

Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response
por: Qian, Jia-Yi, et al.
Publicado: (2023)

Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
por: Zhang, Tian, et al.
Publicado: (2017)

Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
por: Huang, Kun, et al.
Publicado: (2019)

Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
por: Hu, Di, et al.
Publicado: (2022)

Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I–III lung adenocarcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2022)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial
por: Boer, R H de, et al.
Publicado: (1999)

Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma
por: Ford, H E R, et al.
Publicado: (2000)

Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas
por: Iolascon, A, et al.
Publicado: (2000)

Independent factors FOR poor prognosis in young patients with stage I-III breast cancer
por: Erić, Ivan, et al.
Publicado: (2020)

Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo
por: Kauppila, S, et al.
Publicado: (1999)

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
por: Sculier, J-P, et al.
Publicado: (2000)

Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
por: Davies, Rhian Siân, et al.
Publicado: (2017)

Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non–small-cell lung cancer
por: Itonaga, Tomohiro, et al.
Publicado: (2019)

DAP3-mediated cell cycle regulation and its association with radioresistance in human lung adenocarcinoma cell lines
por: Sato, Yoshiaki, et al.
Publicado: (2023)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma
por: Liu, C Q, et al.
Publicado: (1999)

Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer
por: Song, E, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_90pu8n6tloaf6ttnifh97tebss